Arcadia Biosciences, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 18, 2025

Arcadia Biosciences, Inc. Enterprise Value to EBITDA (EV/EBITDA) is NA on July 18, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Arcadia Biosciences, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 0.57 on July 18, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Arcadia Biosciences, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -0.06 on July 18, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Arcadia Biosciences, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 0.36.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization